Saul Richter is the Founder and Managing Partner of Rittenhouse Ventures and has been active within the technology and healthcare investing community for over twenty-five years as a venture capitalist, entrepreneur and technologist. Based in Philadelphia, Rittenhouse Ventures manages over $40 million in assets, and focuses on capital efficient, early-growth B2B software companies with a primary vertical focus on Healthcare and Pharmaceutical IT.
Saul has deep investing experience in digital health dating back 20 years and has previously led investments in Concerro (acquired by Francisco Partners), GSI Health (acquired by Medecision/HCSC) and Halfpenny Technologies (acquired by Accumen), all leading companies in the healthcare verticals in which they focused. Prior to founding Rittenhouse Ventures in 2007, Saul had previous venture capital experience at Himalaya Capital, Lucent’s New Ventures Group and Softbank Capital and had previous deep entrepreneurial experience across the software landscape. Saul has a BA and MBA from Columbia University and is a frequent speaker on technology, healthcare and venture capital trends.